nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP2B6—Sorafenib—liver cancer	0.0978	0.161	CbGbCtD
Clopidogrel—CYP3A5—Sorafenib—liver cancer	0.0771	0.127	CbGbCtD
Clopidogrel—CYP2C8—Sorafenib—liver cancer	0.0741	0.122	CbGbCtD
Clopidogrel—CYP2C19—Sorafenib—liver cancer	0.0622	0.102	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—liver cancer	0.0594	0.0976	CbGbCtD
Clopidogrel—CYP1A2—Sorafenib—liver cancer	0.0574	0.0943	CbGbCtD
Clopidogrel—CYP2C9—Sorafenib—liver cancer	0.0517	0.0849	CbGbCtD
Clopidogrel—ABCB1—Sorafenib—liver cancer	0.0502	0.0824	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—liver cancer	0.0304	0.05	CbGbCtD
Clopidogrel—CYP3A4—Sorafenib—liver cancer	0.03	0.0494	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—liver cancer	0.0182	0.03	CbGbCtD
Clopidogrel—Ticlopidine—CYP2E1—liver cancer	0.00361	0.378	CrCbGaD
Clopidogrel—Ticlopidine—CYP1A1—liver cancer	0.00356	0.373	CrCbGaD
Clopidogrel—Prasugrel—ALB—liver cancer	0.00238	0.249	CrCbGaD
Clopidogrel—Shock—Sorafenib—liver cancer	0.000695	0.00317	CcSEcCtD
Clopidogrel—Fluid retention—Epirubicin—liver cancer	0.000695	0.00317	CcSEcCtD
Clopidogrel—Nervous system disorder—Sorafenib—liver cancer	0.000693	0.00316	CcSEcCtD
Clopidogrel—Blood uric acid increased—Doxorubicin—liver cancer	0.00069	0.00315	CcSEcCtD
Clopidogrel—Aplastic anaemia—Epirubicin—liver cancer	0.000687	0.00314	CcSEcCtD
Clopidogrel—Skin disorder—Sorafenib—liver cancer	0.000686	0.00313	CcSEcCtD
Clopidogrel—Pulmonary embolism—Doxorubicin—liver cancer	0.000677	0.00309	CcSEcCtD
Clopidogrel—Cramps of lower extremities—Epirubicin—liver cancer	0.000672	0.00307	CcSEcCtD
Clopidogrel—Oesophagitis—Epirubicin—liver cancer	0.000669	0.00305	CcSEcCtD
Clopidogrel—Rash maculo-papular—Epirubicin—liver cancer	0.000665	0.00304	CcSEcCtD
Clopidogrel—Bladder pain—Epirubicin—liver cancer	0.000662	0.00302	CcSEcCtD
Clopidogrel—Ecchymosis—Epirubicin—liver cancer	0.000662	0.00302	CcSEcCtD
Clopidogrel—Cystitis noninfective—Doxorubicin—liver cancer	0.000661	0.00302	CcSEcCtD
Clopidogrel—Influenza like illness—Doxorubicin—liver cancer	0.000658	0.003	CcSEcCtD
Clopidogrel—Cystitis—Doxorubicin—liver cancer	0.000654	0.00298	CcSEcCtD
Clopidogrel—Colitis—Doxorubicin—liver cancer	0.00065	0.00297	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000644	0.00294	CcSEcCtD
Clopidogrel—Fluid retention—Doxorubicin—liver cancer	0.000643	0.00293	CcSEcCtD
Clopidogrel—Aplastic anaemia—Doxorubicin—liver cancer	0.000636	0.0029	CcSEcCtD
Clopidogrel—Dyspnoea—Sorafenib—liver cancer	0.00063	0.00287	CcSEcCtD
Clopidogrel—Cramps of lower extremities—Doxorubicin—liver cancer	0.000622	0.00284	CcSEcCtD
Clopidogrel—Dyspepsia—Sorafenib—liver cancer	0.000622	0.00284	CcSEcCtD
Clopidogrel—Oesophagitis—Doxorubicin—liver cancer	0.000619	0.00282	CcSEcCtD
Clopidogrel—Rash maculo-papular—Doxorubicin—liver cancer	0.000616	0.00281	CcSEcCtD
Clopidogrel—Bladder pain—Doxorubicin—liver cancer	0.000612	0.00279	CcSEcCtD
Clopidogrel—Ecchymosis—Doxorubicin—liver cancer	0.000612	0.00279	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Sorafenib—liver cancer	0.00061	0.00278	CcSEcCtD
Clopidogrel—Fatigue—Sorafenib—liver cancer	0.000609	0.00278	CcSEcCtD
Clopidogrel—Hepatic function abnormal—Epirubicin—liver cancer	0.000608	0.00277	CcSEcCtD
Clopidogrel—Constipation—Sorafenib—liver cancer	0.000604	0.00276	CcSEcCtD
Clopidogrel—Pain—Sorafenib—liver cancer	0.000604	0.00276	CcSEcCtD
Clopidogrel—Vascular purpura—Epirubicin—liver cancer	0.000594	0.00271	CcSEcCtD
Clopidogrel—Eczema—Epirubicin—liver cancer	0.000591	0.0027	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Sorafenib—liver cancer	0.000578	0.00264	CcSEcCtD
Clopidogrel—Renal failure acute—Epirubicin—liver cancer	0.000575	0.00263	CcSEcCtD
Clopidogrel—Hepatic function abnormal—Doxorubicin—liver cancer	0.000562	0.00257	CcSEcCtD
Clopidogrel—Urticaria—Sorafenib—liver cancer	0.000561	0.00256	CcSEcCtD
Clopidogrel—Body temperature increased—Sorafenib—liver cancer	0.000559	0.00255	CcSEcCtD
Clopidogrel—Abdominal pain—Sorafenib—liver cancer	0.000559	0.00255	CcSEcCtD
Clopidogrel—Renal impairment—Epirubicin—liver cancer	0.000558	0.00255	CcSEcCtD
Clopidogrel—Dermatitis bullous—Epirubicin—liver cancer	0.000556	0.00254	CcSEcCtD
Clopidogrel—Purpura—Epirubicin—liver cancer	0.000551	0.00252	CcSEcCtD
Clopidogrel—Vascular purpura—Doxorubicin—liver cancer	0.00055	0.00251	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Epirubicin—liver cancer	0.000549	0.0025	CcSEcCtD
Clopidogrel—Eczema—Doxorubicin—liver cancer	0.000547	0.0025	CcSEcCtD
Clopidogrel—Cardiac failure—Epirubicin—liver cancer	0.000544	0.00248	CcSEcCtD
Clopidogrel—Hypoglycaemia—Epirubicin—liver cancer	0.000544	0.00248	CcSEcCtD
Clopidogrel—Renal failure acute—Doxorubicin—liver cancer	0.000532	0.00243	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000531	0.00242	CcSEcCtD
Clopidogrel—Osteoarthritis—Epirubicin—liver cancer	0.000531	0.00242	CcSEcCtD
Clopidogrel—Hypersensitivity—Sorafenib—liver cancer	0.000521	0.00238	CcSEcCtD
Clopidogrel—Renal impairment—Doxorubicin—liver cancer	0.000517	0.00236	CcSEcCtD
Clopidogrel—Dermatitis bullous—Doxorubicin—liver cancer	0.000514	0.00235	CcSEcCtD
Clopidogrel—Purpura—Doxorubicin—liver cancer	0.00051	0.00233	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000508	0.00232	CcSEcCtD
Clopidogrel—Asthenia—Sorafenib—liver cancer	0.000507	0.00231	CcSEcCtD
Clopidogrel—Cardiac failure—Doxorubicin—liver cancer	0.000504	0.0023	CcSEcCtD
Clopidogrel—Hypoglycaemia—Doxorubicin—liver cancer	0.000504	0.0023	CcSEcCtD
Clopidogrel—Pruritus—Sorafenib—liver cancer	0.0005	0.00228	CcSEcCtD
Clopidogrel—Blood creatinine increased—Epirubicin—liver cancer	0.000498	0.00227	CcSEcCtD
Clopidogrel—Osteoarthritis—Doxorubicin—liver cancer	0.000492	0.00224	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000492	0.00224	CcSEcCtD
Clopidogrel—Liver function test abnormal—Epirubicin—liver cancer	0.00049	0.00224	CcSEcCtD
Clopidogrel—Abdominal pain upper—Epirubicin—liver cancer	0.000485	0.00221	CcSEcCtD
Clopidogrel—Diarrhoea—Sorafenib—liver cancer	0.000483	0.00221	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000478	0.00218	CcSEcCtD
Clopidogrel—Gastritis—Epirubicin—liver cancer	0.00047	0.00215	CcSEcCtD
Clopidogrel—Dizziness—Sorafenib—liver cancer	0.000467	0.00213	CcSEcCtD
Clopidogrel—Abdominal distension—Epirubicin—liver cancer	0.000462	0.00211	CcSEcCtD
Clopidogrel—Blood creatinine increased—Doxorubicin—liver cancer	0.000461	0.0021	CcSEcCtD
Clopidogrel—Asthma—Epirubicin—liver cancer	0.000459	0.0021	CcSEcCtD
Clopidogrel—Eosinophilia—Epirubicin—liver cancer	0.000455	0.00207	CcSEcCtD
Clopidogrel—Liver function test abnormal—Doxorubicin—liver cancer	0.000454	0.00207	CcSEcCtD
Clopidogrel—Pancreatitis—Epirubicin—liver cancer	0.00045	0.00205	CcSEcCtD
Clopidogrel—Vomiting—Sorafenib—liver cancer	0.000449	0.00205	CcSEcCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—liver cancer	0.000449	0.00205	CcSEcCtD
Clopidogrel—Angina pectoris—Epirubicin—liver cancer	0.000447	0.00204	CcSEcCtD
Clopidogrel—Rash—Sorafenib—liver cancer	0.000445	0.00203	CcSEcCtD
Clopidogrel—Dermatitis—Sorafenib—liver cancer	0.000445	0.00203	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000443	0.00202	CcSEcCtD
Clopidogrel—Headache—Sorafenib—liver cancer	0.000443	0.00202	CcSEcCtD
Clopidogrel—Bronchitis—Epirubicin—liver cancer	0.000442	0.00201	CcSEcCtD
Clopidogrel—Pancytopenia—Epirubicin—liver cancer	0.000436	0.00199	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—liver cancer	0.000435	0.00199	CcSEcCtD
Clopidogrel—Neutropenia—Epirubicin—liver cancer	0.000429	0.00196	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—liver cancer	0.000428	0.00195	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Epirubicin—liver cancer	0.000427	0.00195	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—liver cancer	0.000425	0.00194	CcSEcCtD
Clopidogrel—Eosinophilia—Doxorubicin—liver cancer	0.000421	0.00192	CcSEcCtD
Clopidogrel—Nausea—Sorafenib—liver cancer	0.00042	0.00191	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—liver cancer	0.000417	0.0019	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—liver cancer	0.000414	0.00189	CcSEcCtD
Clopidogrel—Pneumonia—Epirubicin—liver cancer	0.000412	0.00188	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—liver cancer	0.000409	0.00186	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000406	0.00185	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—liver cancer	0.000403	0.00184	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—liver cancer	0.000402	0.00184	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—liver cancer	0.000401	0.00183	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—liver cancer	0.000399	0.00182	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—liver cancer	0.000398	0.00182	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—liver cancer	0.000398	0.00182	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—liver cancer	0.000397	0.00181	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000395	0.0018	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—liver cancer	0.00039	0.00178	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—liver cancer	0.000387	0.00177	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—liver cancer	0.000386	0.00176	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—liver cancer	0.000384	0.00175	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—liver cancer	0.000382	0.00174	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—liver cancer	0.000381	0.00174	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000376	0.00171	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—liver cancer	0.000372	0.0017	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—liver cancer	0.000371	0.00169	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—liver cancer	0.000369	0.00169	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—liver cancer	0.000369	0.00168	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—liver cancer	0.000368	0.00168	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—liver cancer	0.000368	0.00168	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—liver cancer	0.000368	0.00168	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—liver cancer	0.000368	0.00168	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—liver cancer	0.000368	0.00168	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—liver cancer	0.000366	0.00167	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—liver cancer	0.000363	0.00166	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—liver cancer	0.000362	0.00165	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—liver cancer	0.000361	0.00165	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—liver cancer	0.00036	0.00164	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—liver cancer	0.000358	0.00163	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—liver cancer	0.000357	0.00163	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—liver cancer	0.000355	0.00162	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—liver cancer	0.000354	0.00162	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—liver cancer	0.000354	0.00161	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—liver cancer	0.000348	0.00159	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—liver cancer	0.000343	0.00157	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—liver cancer	0.000343	0.00156	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—liver cancer	0.000342	0.00156	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—liver cancer	0.000341	0.00156	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—liver cancer	0.00034	0.00155	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—liver cancer	0.00034	0.00155	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—liver cancer	0.000338	0.00154	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—liver cancer	0.000336	0.00153	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—liver cancer	0.000335	0.00153	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—liver cancer	0.000333	0.00152	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—liver cancer	0.000333	0.00152	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—liver cancer	0.000332	0.00151	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—liver cancer	0.000331	0.00151	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—liver cancer	0.000328	0.0015	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—liver cancer	0.000322	0.00147	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—liver cancer	0.000322	0.00147	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—liver cancer	0.00032	0.00146	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—liver cancer	0.000318	0.00145	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—liver cancer	0.000317	0.00145	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—liver cancer	0.000315	0.00144	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—liver cancer	0.000309	0.00141	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—liver cancer	0.000309	0.00141	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—liver cancer	0.000308	0.0014	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—liver cancer	0.000307	0.0014	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—liver cancer	0.000306	0.0014	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—liver cancer	0.000298	0.00136	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—liver cancer	0.000296	0.00135	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—liver cancer	0.000296	0.00135	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—liver cancer	0.000292	0.00133	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—liver cancer	0.000287	0.00131	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—liver cancer	0.000287	0.00131	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—liver cancer	0.000286	0.00131	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—liver cancer	0.000286	0.00131	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—liver cancer	0.000285	0.0013	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—liver cancer	0.000283	0.00129	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—liver cancer	0.000281	0.00128	CcSEcCtD
Clopidogrel—Cough—Epirubicin—liver cancer	0.000279	0.00127	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—liver cancer	0.000276	0.00126	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—liver cancer	0.000274	0.00125	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—liver cancer	0.000272	0.00124	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—liver cancer	0.000272	0.00124	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—liver cancer	0.000272	0.00124	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—liver cancer	0.000271	0.00124	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000271	0.00123	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—liver cancer	0.000266	0.00121	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—liver cancer	0.000265	0.00121	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—liver cancer	0.000265	0.00121	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—liver cancer	0.000263	0.0012	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—liver cancer	0.000262	0.00119	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—liver cancer	0.000261	0.00119	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—liver cancer	0.000261	0.00119	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—liver cancer	0.00026	0.00119	CcSEcCtD
Clopidogrel—Infection—Epirubicin—liver cancer	0.000259	0.00118	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—liver cancer	0.000258	0.00118	CcSEcCtD
Clopidogrel—Shock—Epirubicin—liver cancer	0.000257	0.00117	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—liver cancer	0.000256	0.00117	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—liver cancer	0.000256	0.00117	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—liver cancer	0.000254	0.00116	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—liver cancer	0.000252	0.00115	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—liver cancer	0.000252	0.00115	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—liver cancer	0.000252	0.00115	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—liver cancer	0.000251	0.00115	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00025	0.00114	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—liver cancer	0.000244	0.00111	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—liver cancer	0.000244	0.00111	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—liver cancer	0.000242	0.0011	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—liver cancer	0.000242	0.0011	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—liver cancer	0.00024	0.0011	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000238	0.00109	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—liver cancer	0.000238	0.00108	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—liver cancer	0.000237	0.00108	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—liver cancer	0.000236	0.00108	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—liver cancer	0.000235	0.00107	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—liver cancer	0.000234	0.00107	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—liver cancer	0.000233	0.00106	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—liver cancer	0.00023	0.00105	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—liver cancer	0.000226	0.00103	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—liver cancer	0.000225	0.00103	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—liver cancer	0.000225	0.00103	CcSEcCtD
Clopidogrel—Pain—Epirubicin—liver cancer	0.000223	0.00102	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—liver cancer	0.000223	0.00102	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00022	0.001	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—liver cancer	0.000219	0.000997	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—liver cancer	0.000217	0.00099	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—liver cancer	0.000215	0.000983	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—liver cancer	0.000215	0.000982	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—liver cancer	0.000214	0.000974	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—liver cancer	0.000213	0.00097	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000209	0.000952	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—liver cancer	0.000208	0.00095	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—liver cancer	0.000207	0.000947	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—liver cancer	0.000207	0.000943	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—liver cancer	0.000207	0.000943	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—liver cancer	0.000206	0.000942	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—liver cancer	0.000206	0.000942	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—liver cancer	0.000199	0.000908	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—liver cancer	0.000198	0.000901	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—liver cancer	0.000192	0.000878	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—liver cancer	0.000192	0.000876	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—liver cancer	0.000191	0.000871	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—liver cancer	0.000191	0.000871	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—liver cancer	0.000187	0.000855	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—liver cancer	0.000185	0.000843	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—liver cancer	0.000179	0.000815	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—liver cancer	0.000178	0.000812	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—liver cancer	0.000173	0.000791	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—liver cancer	0.000173	0.000788	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—liver cancer	0.000171	0.00078	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—liver cancer	0.000166	0.000758	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—liver cancer	0.000165	0.000754	CcSEcCtD
Clopidogrel—Rash—Epirubicin—liver cancer	0.000165	0.000751	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—liver cancer	0.000164	0.000751	CcSEcCtD
Clopidogrel—Headache—Epirubicin—liver cancer	0.000164	0.000746	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—liver cancer	0.00016	0.000729	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—liver cancer	0.000155	0.000708	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—liver cancer	0.000154	0.000701	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—liver cancer	0.000152	0.000695	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—liver cancer	0.000152	0.000694	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—liver cancer	0.000151	0.000691	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—liver cancer	0.000144	0.000655	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—CASP3—liver cancer	2.79e-05	0.000171	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL2—liver cancer	2.78e-05	0.000171	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GLUL—liver cancer	2.78e-05	0.00017	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CPT1B—liver cancer	2.78e-05	0.00017	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL6—liver cancer	2.77e-05	0.00017	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.76e-05	0.00017	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ALDOB—liver cancer	2.75e-05	0.000169	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.75e-05	0.000169	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTA2—liver cancer	2.75e-05	0.000169	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—liver cancer	2.71e-05	0.000166	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PSMA4—liver cancer	2.71e-05	0.000166	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PSMD10—liver cancer	2.71e-05	0.000166	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—JUN—liver cancer	2.71e-05	0.000166	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALDOB—liver cancer	2.69e-05	0.000165	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CTNNB1—liver cancer	2.69e-05	0.000165	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NR1H4—liver cancer	2.68e-05	0.000164	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.65e-05	0.000163	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTA1—liver cancer	2.65e-05	0.000163	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PSMD10—liver cancer	2.65e-05	0.000163	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PSMA4—liver cancer	2.65e-05	0.000163	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GOT2—liver cancer	2.64e-05	0.000162	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MMP9—liver cancer	2.63e-05	0.000162	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTA3—liver cancer	2.63e-05	0.000162	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CRABP1—liver cancer	2.63e-05	0.000161	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1A—liver cancer	2.62e-05	0.000161	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NAT2—liver cancer	2.62e-05	0.000161	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.58e-05	0.000159	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GOT2—liver cancer	2.58e-05	0.000158	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—HPGDS—liver cancer	2.57e-05	0.000158	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CRABP1—liver cancer	2.56e-05	0.000157	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.56e-05	0.000157	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MAPK8—liver cancer	2.56e-05	0.000157	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.56e-05	0.000157	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—AKT1—liver cancer	2.55e-05	0.000157	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.52e-05	0.000155	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALDOB—liver cancer	2.51e-05	0.000154	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.5e-05	0.000153	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP2E1—liver cancer	2.48e-05	0.000152	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP2E1—liver cancer	2.42e-05	0.000149	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTA4—liver cancer	2.41e-05	0.000148	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CRABP1—liver cancer	2.4e-05	0.000147	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.37e-05	0.000145	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—liver cancer	2.36e-05	0.000145	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.35e-05	0.000144	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTA2—liver cancer	2.35e-05	0.000144	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STAT3—liver cancer	2.34e-05	0.000144	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.33e-05	0.000143	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYCS—liver cancer	2.32e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.3e-05	0.000141	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—HPGDS—liver cancer	2.3e-05	0.000141	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PSMD10—liver cancer	2.29e-05	0.000141	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PSMA4—liver cancer	2.29e-05	0.000141	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.28e-05	0.00014	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GGT1—liver cancer	2.27e-05	0.00014	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GOT1—liver cancer	2.27e-05	0.00014	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYCS—liver cancer	2.27e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTA1—liver cancer	2.26e-05	0.000139	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—HPGDS—liver cancer	2.24e-05	0.000138	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NAT2—liver cancer	2.24e-05	0.000137	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GOT2—liver cancer	2.23e-05	0.000137	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GGT1—liver cancer	2.22e-05	0.000136	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GOT1—liver cancer	2.22e-05	0.000136	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—liver cancer	2.18e-05	0.000134	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TGFB1—liver cancer	2.17e-05	0.000133	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.16e-05	0.000132	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.15e-05	0.000132	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALDOB—liver cancer	2.15e-05	0.000132	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CPT1B—liver cancer	2.14e-05	0.000132	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GLUL—liver cancer	2.14e-05	0.000132	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.11e-05	0.00013	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP2E1—liver cancer	2.1e-05	0.000129	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—HPGDS—liver cancer	2.09e-05	0.000129	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.08e-05	0.000128	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.08e-05	0.000128	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NR1H4—liver cancer	2.07e-05	0.000127	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.05e-05	0.000126	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CRABP1—liver cancer	2.05e-05	0.000126	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PSMD10—liver cancer	2.05e-05	0.000126	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PSMA4—liver cancer	2.05e-05	0.000126	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTP1—liver cancer	2.04e-05	0.000125	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTA3—liver cancer	2.03e-05	0.000125	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.03e-05	0.000125	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—HMOX1—liver cancer	2.02e-05	0.000124	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KRAS—liver cancer	2.01e-05	0.000123	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PSMD10—liver cancer	2e-05	0.000123	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PSMA4—liver cancer	2e-05	0.000123	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTP1—liver cancer	2e-05	0.000123	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GOT2—liver cancer	1.99e-05	0.000122	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—HMOX1—liver cancer	1.97e-05	0.000121	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYCS—liver cancer	1.96e-05	0.00012	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GOT2—liver cancer	1.94e-05	0.000119	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GGT1—liver cancer	1.93e-05	0.000118	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GOT1—liver cancer	1.93e-05	0.000118	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.91e-05	0.000117	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.9e-05	0.000116	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTM1—liver cancer	1.88e-05	0.000115	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP2E1—liver cancer	1.87e-05	0.000115	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.87e-05	0.000115	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PSMA4—liver cancer	1.87e-05	0.000115	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PSMD10—liver cancer	1.87e-05	0.000115	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTA4—liver cancer	1.86e-05	0.000114	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CA—liver cancer	1.85e-05	0.000113	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.84e-05	0.000113	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTM1—liver cancer	1.84e-05	0.000113	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP2E1—liver cancer	1.83e-05	0.000112	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GOT2—liver cancer	1.82e-05	0.000111	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.81e-05	0.000111	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTA2—liver cancer	1.81e-05	0.000111	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—HPGDS—liver cancer	1.79e-05	0.00011	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—liver cancer	1.79e-05	0.00011	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP1A1—liver cancer	1.78e-05	0.000109	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.78e-05	0.000109	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYCS—liver cancer	1.75e-05	0.000108	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTA1—liver cancer	1.75e-05	0.000107	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP1A1—liver cancer	1.74e-05	0.000107	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTP1—liver cancer	1.73e-05	0.000106	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NAT2—liver cancer	1.73e-05	0.000106	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.72e-05	0.000106	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GOT1—liver cancer	1.72e-05	0.000106	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GGT1—liver cancer	1.72e-05	0.000106	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYCS—liver cancer	1.71e-05	0.000105	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HRAS—liver cancer	1.71e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP2E1—liver cancer	1.71e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—HMOX1—liver cancer	1.71e-05	0.000105	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GGT1—liver cancer	1.68e-05	0.000103	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GOT1—liver cancer	1.68e-05	0.000103	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—MTHFR—liver cancer	1.66e-05	0.000102	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALDOB—liver cancer	1.66e-05	0.000102	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.65e-05	0.000101	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL6—liver cancer	1.64e-05	0.0001	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PPARA—liver cancer	1.63e-05	9.99e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—MTHFR—liver cancer	1.62e-05	9.96e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.62e-05	9.95e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.6e-05	9.82e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYCS—liver cancer	1.6e-05	9.8e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PSMD10—liver cancer	1.6e-05	9.79e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PSMA4—liver cancer	1.6e-05	9.79e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PPARA—liver cancer	1.59e-05	9.77e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTM1—liver cancer	1.59e-05	9.76e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CRABP1—liver cancer	1.58e-05	9.7e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GGT1—liver cancer	1.57e-05	9.62e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GOT1—liver cancer	1.57e-05	9.62e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GOT2—liver cancer	1.55e-05	9.52e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTP1—liver cancer	1.54e-05	9.48e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—HMOX1—liver cancer	1.52e-05	9.35e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—AKT1—liver cancer	1.51e-05	9.26e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTP1—liver cancer	1.51e-05	9.25e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP1A1—liver cancer	1.51e-05	9.25e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—HMOX1—liver cancer	1.49e-05	9.12e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP2E1—liver cancer	1.46e-05	8.95e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTM1—liver cancer	1.42e-05	8.71e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.41e-05	8.67e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTP1—liver cancer	1.41e-05	8.64e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—MTHFR—liver cancer	1.41e-05	8.62e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CG—liver cancer	1.39e-05	8.56e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—HMOX1—liver cancer	1.39e-05	8.52e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTM1—liver cancer	1.39e-05	8.5e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—HPGDS—liver cancer	1.38e-05	8.48e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PPARA—liver cancer	1.38e-05	8.46e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYCS—liver cancer	1.37e-05	8.38e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CG—liver cancer	1.36e-05	8.36e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PPARG—liver cancer	1.35e-05	8.26e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP1A1—liver cancer	1.35e-05	8.26e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GOT1—liver cancer	1.34e-05	8.22e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GGT1—liver cancer	1.34e-05	8.22e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PPARG—liver cancer	1.32e-05	8.07e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP1A1—liver cancer	1.31e-05	8.06e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTM1—liver cancer	1.29e-05	7.94e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—MTHFR—liver cancer	1.25e-05	7.7e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.24e-05	7.6e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PSMA4—liver cancer	1.23e-05	7.56e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PSMD10—liver cancer	1.23e-05	7.56e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PPARA—liver cancer	1.23e-05	7.55e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP1A1—liver cancer	1.23e-05	7.53e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CD—liver cancer	1.23e-05	7.52e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—MTHFR—liver cancer	1.22e-05	7.51e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ALB—liver cancer	1.21e-05	7.43e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTP1—liver cancer	1.2e-05	7.38e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PPARA—liver cancer	1.2e-05	7.37e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CD—liver cancer	1.2e-05	7.35e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GOT2—liver cancer	1.2e-05	7.35e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—HMOX1—liver cancer	1.19e-05	7.28e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ALB—liver cancer	1.18e-05	7.26e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CG—liver cancer	1.18e-05	7.24e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—MTHFR—liver cancer	1.14e-05	7.02e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PPARG—liver cancer	1.14e-05	6.99e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP2E1—liver cancer	1.13e-05	6.91e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PPARA—liver cancer	1.12e-05	6.88e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTM1—liver cancer	1.11e-05	6.79e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.11e-05	6.78e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CB—liver cancer	1.07e-05	6.56e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CG—liver cancer	1.05e-05	6.47e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYCS—liver cancer	1.05e-05	6.47e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP1A1—liver cancer	1.05e-05	6.43e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CB—liver cancer	1.04e-05	6.41e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CD—liver cancer	1.04e-05	6.37e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GOT1—liver cancer	1.03e-05	6.34e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GGT1—liver cancer	1.03e-05	6.34e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CG—liver cancer	1.03e-05	6.31e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ALB—liver cancer	1.02e-05	6.29e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PPARG—liver cancer	1.02e-05	6.24e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.01e-05	6.18e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PPARG—liver cancer	9.93e-06	6.09e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—MTHFR—liver cancer	9.77e-06	6e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CG—liver cancer	9.61e-06	5.9e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPARA—liver cancer	9.59e-06	5.88e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTP1—liver cancer	9.29e-06	5.7e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PPARG—liver cancer	9.27e-06	5.69e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CD—liver cancer	9.26e-06	5.68e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—HMOX1—liver cancer	9.16e-06	5.62e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ALB—liver cancer	9.14e-06	5.61e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CB—liver cancer	9.05e-06	5.55e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CD—liver cancer	9.04e-06	5.55e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALB—liver cancer	8.93e-06	5.48e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.61e-06	5.28e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTM1—liver cancer	8.53e-06	5.24e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CD—liver cancer	8.45e-06	5.18e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALB—liver cancer	8.34e-06	5.12e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CG—liver cancer	8.21e-06	5.04e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP1A1—liver cancer	8.09e-06	4.96e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CB—liver cancer	8.07e-06	4.95e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPARG—liver cancer	7.92e-06	4.86e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CB—liver cancer	7.88e-06	4.84e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—MTHFR—liver cancer	7.54e-06	4.63e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPARA—liver cancer	7.4e-06	4.54e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CB—liver cancer	7.36e-06	4.52e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CD—liver cancer	7.22e-06	4.43e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALB—liver cancer	7.12e-06	4.37e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CA—liver cancer	6.51e-06	4e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CA—liver cancer	6.37e-06	3.91e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CG—liver cancer	6.34e-06	3.89e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CB—liver cancer	6.29e-06	3.86e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPARG—liver cancer	6.12e-06	3.75e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CD—liver cancer	5.57e-06	3.42e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CA—liver cancer	5.51e-06	3.38e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALB—liver cancer	5.5e-06	3.37e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKT1—liver cancer	5.32e-06	3.27e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKT1—liver cancer	5.2e-06	3.19e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CA—liver cancer	4.92e-06	3.02e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CB—liver cancer	4.86e-06	2.98e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CA—liver cancer	4.8e-06	2.95e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKT1—liver cancer	4.5e-06	2.76e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CA—liver cancer	4.49e-06	2.75e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKT1—liver cancer	4.02e-06	2.47e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKT1—liver cancer	3.92e-06	2.41e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CA—liver cancer	3.84e-06	2.35e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKT1—liver cancer	3.67e-06	2.25e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKT1—liver cancer	3.13e-06	1.92e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CA—liver cancer	2.96e-06	1.82e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKT1—liver cancer	2.42e-06	1.48e-05	CbGpPWpGaD
